Infection with Nontuberculous Mycobacteria (NTM) species is increasing in prevalence in both endemic and non-endemic areas. 1 Clinically, NTM infections most commonly present as skin and soft tissue infection, pulmonary disease, lymphadenitis or disseminated disease 2 but may less likely present in locations such as the eyes, musculoskeletal system or central nervous system (CNS). 3 When the skin and soft tissues are involved, infection may appear as papules, pustules, plaques, nodules, abscesses, panniculitis, folliculitis, or lymphangitis. Although frequently initially indolent, lesions may ulcerate, and may exhibit proximal lymphangitic spread. 4,5 Such varied presentations elicit a broad differential of chronic infectious and non-infectious diagnoses. 5 Chronic, untreated sequelae of cutaneous NTM may be as mild as pigmentary changes or as severe as nerve palsies, permanent disfigurement and bacteremia, depending on the integrity of the host's immune system. 6,7 Accurate diagnosis of NTM is important to ensure appropriate antibiotic selection.